Skip to main content

Persistent Asset Partners Ltd

SEC CIK
0002056052
Latest filing
Aug 6, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Persistent Asset Partners Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q1 2025)
0
Sold out in Q1 2025
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q4 2024
Holdings of CRNX by Persistent Asset Partners Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20250$00.0%−13,184−100.0%Sold outHolders
Q4 202413,184$531.3K0.5%–No prior filingHolders